|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/05 | (2006.01) |
| A61K 47/10 | (2017.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| F26B 5/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3228319 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17173249.8 |
| Date of filing the European patent application | 2012-04-25 | |
| (97) | Date of publication of the European application | 2017-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-03 |
| (46) | Date of publication of the claims translation | 2020-09-25 |
| (30) | Number | Date | Country code |
| 1150371 | 2011-04-28 | SE | |
| 201161535126 P | 2011-09-15 | US |
| (72) |
SPIRA, Jack, SE
LEHMANN, Fredrik, SE
|
| (73) |
Oncopeptides Innovation AB,
Luntmakargatan 46, 111 37 Stockholm,
SE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Liofilizuotas citotoksinių dipeptidų preparatas |
| LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES |
| Payment date | Validity (years) | Amount | |
| 2024-04-08 | 13 | 289.00 EUR |
| 2025-04-25 |